Ege S. David's Insider Trades & SAST Disclosures
Ege S. David's most recent trade in Seres Therapeutics Inc was a trade of 2,969 Restricted Stock Units done . Disclosure was reported to the exchange on Aug. 15, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Ege S. David.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Seres Therapeutics Inc | David S. Ege | See Remarks | 15 Aug 2024 | 2,969 | 29,688 | - | - | Restricted Stock Units | ||
| Seres Therapeutics Inc | David S. Ege | See Remarks | 15 Aug 2024 | 2,969 | 78,703 (0%) | 0% | - | Common Stock | ||
| Seres Therapeutics Inc | David S. Ege | See Remarks | 15 Aug 2024 | 1,128 | 77,575 (0%) | 0% | 0.8 | 948 | Common Stock | |
| Seres Therapeutics Inc | David S. Ege | See Remarks | 15 May 2024 | 2,968 | 76,824 (0%) | 0% | - | Common Stock | ||
| Seres Therapeutics Inc | David S. Ege | See Remarks | 15 May 2024 | 2,968 | 32,657 | - | - | Restricted Stock Units | ||
| Seres Therapeutics Inc | David S. Ege | See Remarks | 15 May 2024 | 1,090 | 75,734 (0%) | 0% | 0.9 | 1,025 | Common Stock | |
| Seres Therapeutics Inc | Ege S. David | See Remarks | 14 Feb 2024 | 287,905 | 287,905 | - | - | Stock Option (Right to Buy) | ||
| Seres Therapeutics Inc | S. Ege David | See Remarks | 14 Feb 2024 | 187,500 | 187,500 | - | - | Stock Option (Right to Buy) | ||
| Seres Therapeutics Inc | S. David Ege | See Remarks | 14 Feb 2024 | 31,250 | 31,250 | - | - | Restricted Stock Units | ||
| Seres Therapeutics Inc | S. David Ege | See Remarks | 14 Feb 2024 | 11,875 | 78,866 (0%) | 0% | - | Common Stock | ||
| Seres Therapeutics Inc | Ege David S. | See Remarks | 14 Feb 2024 | 11,875 | 35,625 | - | - | Restricted Stock Units | ||
| Seres Therapeutics Inc | Ege David S. | See Remarks | 14 Feb 2024 | 5,010 | 73,856 (0%) | 0% | 1.1 | 5,411 | Common Stock | |
| Seres Therapeutics Inc | David S. Ege | See Remarks | 27 Apr 2023 | 20,000 | 66,734 (0%) | 0% | 0 | Common stock | ||
| Seres Therapeutics Inc | David S. Ege | See Remarks | 27 Apr 2023 | 7,038 | 59,696 (0%) | 0% | 5.2 | 36,527 | Common stock | |
| Seres Therapeutics Inc | David S. Ege | See Remarks | 03 Feb 2023 | 95,000 | 95,000 | - | - | Stock Option (Right to Buy) | ||
| Seres Therapeutics Inc | David S. Ege | See Remarks | 03 Feb 2023 | 47,500 | 47,500 | - | - | Restricted Stock Units | ||
| Seres Therapeutics Inc | David S. Ege | See Remarks | 27 Oct 2022 | 20,000 | 51,746 (0%) | 0% | 0 | Common stock | ||
| Seres Therapeutics Inc | David S. Ege | See Remarks | 27 Oct 2022 | 5,012 | 46,734 (0%) | 0% | 7.9 | 39,745 | Common stock | |
| Seres Therapeutics Inc | David S. Ege | See Remarks | 05 Jul 2022 | 31,746 | 31,746 (0%) | 0% | 3.2 | 100,000 | COMMON STOCK | |
| Seres Therapeutics Inc | David S. Ege | See Remarks | 04 Feb 2022 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) | ||
| Seres Therapeutics Inc | David S. Ege | See Remarks | 19 Oct 2020 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges